Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer) [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study comparing giredestrant with physician's choice of endocrine therapy in previously treated estrogen recepto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Giredestrant (giredestrant)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-03-10